Follow
Myrto Samara
Myrto Samara
Verified email at uth.gr - Homepage
Title
Cited by
Cited by
Year
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
S Leucht, A Cipriani, L Spineli, D Mavridis, D Örey, F Richter, M Samara, ...
The Lancet 382 (9896), 951-962, 2013
29242013
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
M Huhn, A Nikolakopoulou, J Schneider-Thoma, M Krause, M Samara, ...
The Lancet 394 (10202), 939-951, 2019
12032019
Dose equivalents for antipsychotic drugs: the DDD method
S Leucht, M Samara, S Heres, JM Davis
Schizophrenia bulletin 42 (suppl_1), S90-S94, 2016
5372016
Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors
S Leucht, C Leucht, M Huhn, A Chaimani, D Mavridis, B Helfer, M Samara, ...
American Journal of Psychiatry 174 (10), 927-942, 2017
5062017
Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic overview of meta-analyses
M Huhn, M Tardy, LM Spineli, W Kissling, H Foerstl, G Pitschel-Walz, ...
JAMA psychiatry 71 (6), 706-715, 2014
4472014
Dose equivalents for second-generation antipsychotics: the minimum effective dose method
S Leucht, M Samara, S Heres, MX Patel, SW Woods, JM Davis
Schizophrenia bulletin 40 (2), 314-326, 2014
3542014
Efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia: a network meta-analysis
MT Samara, M Dold, M Gianatsi, A Nikolakopoulou, B Helfer, G Salanti, ...
JAMA psychiatry 73 (3), 199-210, 2016
3372016
Dose equivalents for second-generation antipsychotic drugs: the classical mean dose method
S Leucht, M Samara, S Heres, MX Patel, T Furukawa, A Cipriani, ...
Schizophrenia bulletin 41 (6), 1397-1402, 2015
2582015
Efficacy and safety of antidepressants added to antipsychotics for schizophrenia: a systematic review and meta-analysis
B Helfer, MT Samara, M Huhn, E Klupp, C Leucht, Y Zhu, RR Engel, ...
American Journal of Psychiatry 173 (9), 876-886, 2016
2402016
The longitudinal course of schizophrenia across the lifespan: clinical, cognitive, and neurobiological aspects
U Heilbronner, M Samara, S Leucht, P Falkai, TG Schulze
Harvard review of psychiatry 24 (2), 118-128, 2016
1642016
Early improvement as a predictor of later response to antipsychotics in schizophrenia: a diagnostic test review
MT Samara, C Leucht, MM Leeflang, IG Anghelescu, YC Chung, ...
American journal of psychiatry 172 (7), 617-629, 2015
1622015
Antipsychotic drugs: from receptor-binding profiles to metabolic side effects
S Siafis, D Tzachanis, M Samara, G Papazisis
Current neuropharmacology 16 (8), 1210-1223, 2018
1562018
Combining randomized and non‐randomized evidence in network meta‐analysis
O Efthimiou, D Mavridis, TPA Debray, M Samara, M Belger, GCM Siontis, ...
Statistics in medicine 36 (8), 1210-1226, 2017
1532017
Initial severity of schizophrenia and efficacy of antipsychotics: participant-level meta-analysis of 6 placebo-controlled studies
TA Furukawa, SZ Levine, S Tanaka, Y Goldberg, M Samara, JM Davis, ...
JAMA psychiatry 72 (1), 14-21, 2015
1202015
Haloperidol versus first‐generation antipsychotics for the treatment of schizophrenia and other psychotic disorders
M Dold, MT Samara, C Li, M Tardy, S Leucht
Cochrane Database of Systematic Reviews, 2015
1082015
How many patients with schizophrenia do not respond to antipsychotic drugs in the short term? An analysis based on individual patient data from randomized controlled trials
MT Samara, A Nikolakopoulou, G Salanti, S Leucht
Schizophrenia bulletin 45 (3), 639-646, 2019
1012019
Equipercentile linking of scales measuring functioning and symptoms: examining the GAF, SOFAS, CGI-S, and PANSS
MT Samara, RR Engel, A Millier, J Kandenwein, M Toumi, S Leucht
European Neuropsychopharmacology 24 (11), 1767-1772, 2014
672014
Impact of Silymarin in individuals with nonalcoholic fatty liver disease: A systematic review and meta-analysis
G Kalopitas, C Antza, I Doundoulakis, A Siargkas, E Kouroumalis, ...
Nutrition 83, 111092, 2021
562021
Recent meta-analyses neglect previous systematic reviews and meta-analyses about the same topic: a systematic examination
B Helfer, A Prosser, MT Samara, JR Geddes, A Cipriani, JM Davis, ...
BMC medicine 13, 1-8, 2015
552015
Systematic review with meta‐analysis: the effect of vitamin E supplementation in adult patients with non‐alcoholic fatty liver disease
A Vadarlis, C Antza, DR Bakaloudi, I Doundoulakis, G Kalopitas, ...
Journal of Gastroenterology and Hepatology 36 (2), 311-319, 2021
532021
The system can't perform the operation now. Try again later.
Articles 1–20